Mestastop is a company that is aiming to create a cancer metastasis focussed platform.

Basic Information

Founded in the year 2018, Mestastop’s unique edge is to be “the metastasis specialists” by creating a R&D leveraging the unique strengths of being in India. The company is based in Bengaluru, where it is bringing together a cross-functional team, trained in discovery, diagnostics and AI, supported by the state-of-the-art infrastructure available in India’s best bioscience incubators. Mestastop is creating a cancer metastasis focussed platform, which uses wet lab biology and predictive analytics to identify and distinguish unique properties of metastasis and leverage them for drug discovery and patient treatment. Mestastop has mimicked metastasis biology in multiple steps, each being represented by a cell-based functional assay. Summatively, these assays provide a biological model that will expedite the in vitro drug discovery efforts against metastasis. The colorectal and triple negative breast cancer-based platform is ready and Mestastop is normalising the colorectal platform with patient sample data. See more

Legal Name

:

Mestastop Solutions Pvt Ltd

Headquarters

:

Bengaluru, Karnataka, India

Business Model

:

B2B 

Founding Date

:

2018

No. of Employees

:

11 to 20

Core Team

:
1.

Debabani Roy Chowdhury

Co-Founder and Director

2.

Arnab Roy Chowdhury

Co-Founder

Funding

Total Funding

$173.3k

Investors

:

1.

CIIE.CO

2.

Mumbai Angels

Detail Round Breakdown

Round 1

$173k

Series Name

:

SEED

Date

:

19th Oct 2021

Investors

:
1.

CIIE.CO

2.

IKP Knowledge Park